Skip to Main Content

Paper Details

Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure, and Hypertension in Mice and Humans.
Circulation
12
2021
Diabetes, FXYD1, Humans, Hypertension, K, Mice, Na, PLM3SA, Phospholemman, R70C, Ser63, Ser68, aging, alanines, essential hypertension, human, human embryonic kidney cells, human genomic databases, humans, men, mice, mouse, nonsynonymous coding variant, ouabain, phenylephrine, phospholemman, rare allele, rs61753924, serines, single nucleotide polymorphism, smooth muscle Na/K ATPase
Author NameAffiliation
Helen R WarrenBritish Heart Foundation Centre of Research Excellence, King's College London, The William Harvey Research Institute (O.P., National Institute for Health Research, Biomedical Research Centre (H.R.W., Barts and The London School of Medicine and Dentistry, Queen Mary University of London, University of Oxford, University of Dundee, United Kingdom. Institute of Cardiovascular and Medical Sciences, University of Glasgow
Alex S F DoneyBritish Heart Foundation Centre of Research Excellence, King's College London, The William Harvey Research Institute (O.P., National Institute for Health Research, Biomedical Research Centre (H.R.W., Barts and The London School of Medicine and Dentistry, Queen Mary University of London, University of Oxford, University of Dundee, United Kingdom. Institute of Cardiovascular and Medical Sciences, University of Glasgow
Alex S F DoneyBritish Heart Foundation Centre of Research Excellence, King's College London, The William Harvey Research Institute (O.P., National Institute for Health Research, Biomedical Research Centre (H.R.W., Barts and The London School of Medicine and Dentistry, Queen Mary University of London, University of Oxford, University of Dundee, United Kingdom. Institute of Cardiovascular and Medical Sciences, University of Glasgow
Colin N A PalmerBritish Heart Foundation Centre of Research Excellence, King's College London, The William Harvey Research Institute (O.P., National Institute for Health Research, Biomedical Research Centre (H.R.W., Barts and The London School of Medicine and Dentistry, Queen Mary University of London, University of Oxford, University of Dundee, United Kingdom. Institute of Cardiovascular and Medical Sciences, University of Glasgow
Colin N A PalmerBritish Heart Foundation Centre of Research Excellence, King's College London, The William Harvey Research Institute (O.P., National Institute for Health Research, Biomedical Research Centre (H.R.W., Barts and The London School of Medicine and Dentistry, Queen Mary University of London, University of Oxford, University of Dundee, United Kingdom. Institute of Cardiovascular and Medical Sciences, University of Glasgow
Mark J CaulfieldBritish Heart Foundation Centre of Research Excellence, King's College London, The William Harvey Research Institute (O.P., National Institute for Health Research, Biomedical Research Centre (H.R.W., Barts and The London School of Medicine and Dentistry, Queen Mary University of London, University of Oxford, University of Dundee, United Kingdom. Institute of Cardiovascular and Medical Sciences, University of Glasgow
Mark J CaulfieldBritish Heart Foundation Centre of Research Excellence, King's College London, The William Harvey Research Institute (O.P., National Institute for Health Research, Biomedical Research Centre (H.R.W., Barts and The London School of Medicine and Dentistry, Queen Mary University of London, University of Oxford, University of Dundee, United Kingdom. Institute of Cardiovascular and Medical Sciences, University of Glasgow
  • 1 - 7

Datasets